Clinuvel Pharmaceuticals | CUV - Operating Profit

Stock Price
9.32
Daily Change
0.31 3.44%
Monthly
-6.80%
Yearly
-7.45%
Q2 Forecast
8.82

Clinuvel Pharmaceuticals reported AUD13.51M in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Avita Medical AUD -10.41M 742K Dec/2025
Medical Developments International AUD -36K 444K Dec/2025
Mesoblast USD -30.96M 11.14M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -21.57M 13.07M Dec/2025
PYC Therapeutics AUD -22.59M 9.12M Dec/2025
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025